Pharmaceuticals Africa

Africa Narcolepsy Treatment Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Africa Narcolepsy Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $54.1 Mn Placeholder estimate
Estimate 2025 $59.1 Mn 1.4% of the global market
Projected 2034 $131.7 Mn 122.6% Adds $72.5 Mn over 9 forecast years
CAGR 2025–2034 9.3% Faster than 46% of 180 Pharmaceuticals markets here
Key players 5
  • Africa is 1.45% of the global market.
  • Among regions, the largest is North America at $1.90 Bn.
  • Fastest growing: APAC at 9.6% a year.
  • Africa ranks 6th of 6 by size among regions.

Market size projection

Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$72.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Narcolepsy Treatment Market market size by year, Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $54.1 Mn — —
2025 (base) $59.1 Mn +$5.0 Mn —
2026 (forecast) $64.6 Mn +$5.5 Mn +9.3%
2027 (forecast) $70.6 Mn +$6.0 Mn +19.5%
2028 (forecast) $77.2 Mn +$6.6 Mn +30.6%
2029 (forecast) $84.4 Mn +$7.2 Mn +42.7%
2030 (forecast) $92.2 Mn +$7.8 Mn +56%
2031 (forecast) $100.8 Mn +$8.6 Mn +70.5%
2032 (forecast) $110.2 Mn +$9.4 Mn +86.4%
2033 (forecast) $120.5 Mn +$10.2 Mn +103.7%
2034 (forecast) $131.7 Mn +$11.2 Mn +122.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Africa Narcolepsy Treatment Market Analysis at a glance
Market size, 2025$59.1 Mn placeholder estimate
Forecast, 2034$131.7 Mn placeholder estimate
Growth (CAGR), 2025–20349.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledNarcolepsy Therapeutics
SegmentsDrug class, type and end user (see all)
Key playersJazz Pharmaceuticals, Harmony Biosciences, Avadel Pharmaceuticals, Takeda Pharmaceutical Company Ltd, Axsome Therapeutics (see all)
Regulator in AfricaAMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Africa Narcolepsy Treatment Market Analysis Executive Summary

Narcolepsy treatments reduce daytime sleepiness and sudden muscle weakness in people with this sleep disorder.

Key segments of the narcolepsy Treatment market include drug class (Oxybates, Wake-Promoting Agents and H3 Antagonists) and type (Type 1 and Type 2).

Bar chart: Africa Narcolepsy Treatment market size, 2024–2034, placeholder estimates. $54.1 Mn in 2024, $59.1 Mn in 2025 and $131.7 Mn in 2034, 9.3% CAGR.
Africa Narcolepsy Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Africa Narcolepsy Treatment Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the narcolepsy Treatment market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the narcolepsy Treatment market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the narcolepsy Treatment market.

Competitive Landscape for Narcolepsy Treatment Market in Africa

The narcolepsy Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Narcolepsy Treatment Market in Africa

Narcolepsy Treatment in Africa: rules and payment

The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together.⁠[1] In some of the countries we cover here, medicines are approved by EDA (Egypt)⁠[2], PPB (Kenya)⁠[3] and SAHPRA (South Africa)⁠[4]. How care is paid for in some of these countries: universal health insurance (Egypt)⁠[5], the SHA (Kenya)⁠[6] and planned National Health Insurance (South Africa)⁠[7].

[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.

[2] Egyptian Drug Authority. Checked 14 Nov 2026.

[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.

[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.

[5] Universal Health Insurance Authority. Checked 14 Nov 2026.

[6] Social Health Authority. Checked 14 Nov 2026.

[7] National Department of Health. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for narcolepsy Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Narcolepsy Treatment right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Narcolepsy Treatment in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Narcolepsy Treatment market in Africa?
Placeholder estimate: about $59.1 Mn in 2025, rising to about $131.7 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Narcolepsy Treatment market in Africa growing?
Placeholder estimate: about 9.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Narcolepsy Treatment market report cover?
The report splits the market by drug class (Oxybates, Wake-Promoting Agents, H3 Antagonists, Orexin Agonists), type (Type 1, Type 2) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Narcolepsy Treatment market?
Key players include Jazz Pharmaceuticals, Harmony Biosciences, Avadel Pharmaceuticals, Takeda Pharmaceutical Company Ltd and Axsome Therapeutics.
What is driving the Narcolepsy Treatment market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the narcolepsy Treatment market.
Who regulates Narcolepsy Treatment in Africa?
The African Medicines Agency (AMA), set up by an African Union treaty in force since November 2021, aims to bring the work of national regulators together. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How much research is published on Narcolepsy Treatment?
PubMed lists 23 papers on Narcolepsy Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Africa

See all

Related on brain and nerves and sleep

See the topic